Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, Jia-Yi, Englund, Elisabet, Holton, Janice L, Soulet, Denis, Hagell, Peter, Lees, Andrew J, Lashley, Tammaryn, Quinn, Niall P +6 more·2008·Nature Medicine

DOI 10.1038/nm1746

Cited by (1,002)

Items 901–1,000 of 1,002

Seeding Propensity and Characteristics of Pathogenic αSyn Assemblies in Formalin-Fixed Human Tissue from the Enteric Nervous System, Olfactory Bulb, and Brainstem in Cases Staged for Parkinson’s Disease
Alexis Fenyi, Charles J. Duyckaerts, Luc Bousset, Heiko Braak, Kelly Del Tredici, Ronald Melki, on behalf of the Brainbank Neuro-CEB Neuropathology Network · 2021 · Cells
The Roles of ATP13A2 Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson’s Disease
Fan Zhang, Zhiwei Wu, Fei Long, Jieqiong Tan, Ni Gong, Xiaorong Li, Changwei Lin · 2022 · Frontiers in Cellular Neuroscience
Striatal transplantation for multiple system atrophy — Are grafts affected by α-synucleinopathy?
Nadia Stefanova, Monika Hainzer, Sylvia Stemberger, Sébastien Couillard‐Després, Ludwig Aigner, Werner H Poewe, Gregor Karl Wenning · 2009 · Experimental Neurology
Synaptic Protein Alterations in Parkinson’s Disease
Ilse Sanet Pienaar, David John Burn, Christopher M. Morris, David Trevor Dexter · 2011 · Molecular Neurobiology
Protein aggregation and prionopathies
Marianne L. Renner, Ronald Melki · 2014 · Pathologie Biologie
Transmission of Soluble and Insoluble α-Synuclein to Mice
Daryl Rhys Jones, Marion Delenclos, Ann-Marie T. Baine, Michael A. Deture, Melissa Erin Murray, Dennis W. Dickson, Pamela J. McLean · 2015 · Journal of Neuropathology & Experimental Neurology
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson’s disease
Darren M. O’Hara, Suneil Kumar Kalia, Lorraine V. Kalia · 2020 · Critical Reviews in Clinical Laboratory Sciences
α-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: correlation with olfactory projections
Isabel Úbeda‐Bañón, Daniel Saiz‐Sánchez, Carlos de la Rosa‐Prieto, Alino Martı́nez-Marcos · 2011 · Brain Structure and Function
Off-pathway α -synuclein oligomers seem to alter α -synuclein turnover in a cell model but lack seeding capability in vivo
Therese Fagerqvist, Thomas Näsström, Elisabet Ihse, Veronica Lindström, Charlotte Sahlin, Stina M. Fangmark Tucker, Alex Kasaryan, Mikael Karlsson, Fredrik K. Nikolajeff, Heinrich Schell et al. · 2013 · Amyloid
Membrane Trafficking Illuminates a Path to Parkinson’s Disease
Takafumi Hasegawa, Naoto Sugeno, Akio Kikuchi, Toru Baba, Masashi Aoki · 2017 · The Tohoku Journal of Experimental Medicine
Testing the Protein Propagation Hypothesis of Parkinson Disease
Alain Dagher, Yashar Zeighami · 2018 · Journal of Experimental Neuroscience
α-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease
Yakum Benard Mingo, Martha L. Escobar Galvis, Michael X. Henderson · 2025 · Neurobiology of Disease
The influence of the glymphatic system on α-synuclein propagation: the role of aquaporin-4
Douglas M. Lopes, Sophie K. Llewellyn, Sheila E Bury, Jiazheng Wang, Jack A. Wells, Matthew E. Gegg, Guglielmo Verona, Mark F. Lythgoe, Ian F. Harrison · 2025 · Brain
Targeting α‐Synuclein as a therapy for Parkinson's disease: The battle begins
C. Warren Olanow, Jeffrey H. Kordower · 2017 · Movement Disorders
Progress toward an integrated understanding of Parkinson’s disease
Maxime W.C. Rousseaux, Joshua M Shulman, Joseph J. Jankovic · 2017 · F1000Research
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Adam J. Bindas, Subhash Kulkarni, Ryan A. Koppes, Abigail N. Koppes · 2020 · Acta Biomaterialia
Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
Gabriela Henrı́quez, Mahesh Narayan · 2023 · Exploration of Neuroprotective Therapy
Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system
Mingyue Jin, Shengming Wang, Xiaodie Gao, Zhenyou Zou, Shinji Hirotsune, Liyuan Sun · 2023 · Neural Regeneration Research
Radially Branched Deployment for More Efficient Cell Transplantation at the Scale of the Human Brain
Matthew T. Silvestrini, Dali Yin, Valerie G. Coppes, Preeti Mann, Alastair J. Martin, Paul Larson, Philip A. Starr, Nalin M. Gupta, S. Scott Panter, Tejal Ashwin Desai et al. · 2013 · Stereotactic and Functional Neurosurgery
Convergent molecular defects underpin diverse neurodegenerative diseases
George K. Tofaris, Noel J. Buckley · 2018 · Journal of Neurology Neurosurgery & Psychiatry
Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis
Stefan Bräuer, Vitaly L. Zimyanin, Andreas Hermann · 2018 · Journal of Neural Transmission
Outcome of cell suspension allografts in a patient with Huntington's disease
Alexander Maxan, Sarah Mason, Martine Saint‐Pierre, Emma Smith, Aileen K. Ho, Timothy Harrower, Colin Watts, Yen Tai, Nicola Pavese, Julie C. Savage et al. · 2018 · Annals of Neurology
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Asuka Morizane · 2019 · Rinsho Shinkeigaku
Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across Severity
Jamie C. Blair, Matthew J. Barrett, James T. Patrie, Joseph L. Flanigan, Scott A. Sperling, W. Jeffrey Elias, T. Jason Druzgal · 2019 · Frontiers in Neurology
Immortalization of neuronal progenitors using SV 40 large T antigen and differentiation towards dopaminergic neurons
A. Alwin Prem Anand, S. Gowri Sankar, V. Kokila Vani · 2012 · Journal of Cellular and Molecular Medicine
Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders
Hansen Wang, Laurie C. Doering · 2012 · Neural Plasticity
Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins
Hasier Eraña, Vanesa Venegas, Jorge M. Charco, Joaquı́n Castilla · 2016 · Biochemical and Biophysical Research Communications
Molecular Mechanism for the Suppression of Alpha Synuclein Membrane Toxicity by an Unconventional Extracellular Chaperone
Rashik Ahmed, Jinfeng Huang, Daniel K. Weber, Tata Gopinath, Gianluigi Veglia, Madoka Akimoto, Adree Khondker, Maikel Christian Rheinstadter, Vincent A. Huynh, Ryan Gavin Wylie et al. · 2020 · Journal of the American Chemical Society
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri · 2020 · Frontiers in Cell and Developmental Biology
Peripherally misfolded proteins exacerbate ischemic stroke-induced neuroinflammation and brain injury
Yanying Liu, Kalpana Subedi, Aravind Baride, Svetlana Romanova, Eduardo Alberto Callegari, Christa C. Huber, Xuejun Wang, Hongmin Wang · 2021 · Journal of Neuroinflammation
To be or not to be accepted: the role of immunogenicity of neural stem cells following transplantation into the brain in animal and human studies
Philipp Capetian, Máté Daniel Döbrössy, Christian Winkler, Marco Prinz, Guido Nikkhah · 2011 · Seminars in Immunopathology
In vitro screen of prion disease susceptibility genes using the scrapie cell assay
Craig A. Brown, Christian Schmidt, Mark Poulter, Holger Hummerich, Peter‐Christian Klöhn, Parmjit Jat, Simon Mead, John Collinge, Sarah E. Lloyd · 2014 · Human Molecular Genetics
Visualization of prion-like transfer in Huntington's disease models
Anne H. P. Jansen, Kevin Llewelyn Batenburg, Eline Pecho‐Vrieseling, Eric A. Reits · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Primary tissue for cellular brain repair in Parkinson's disease: Promise, problems and the potential of biomaterials
Niamh Moriarty, Clare L. Parish, Eilís Dowd · 2018 · European Journal of Neuroscience
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
Jimenez-Ferrer, Itzia, Bäckström, Filip, Dueñas-Rey, Alfredo, Jewett, Michael, Boza-Serrano, Antonio, Luk, Kelvin C., Deierborg, Tomas, Swanberg, Maria · 2021 · Brain, Behavior, and Immunity
New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeutics
S. Pablo Sardi, Tanya Simuni · 2018 · Parkinsonism & Related Disorders
Appendectomy, Tonsillectomy and Parkinson's Disease Risk: A Swedish Register-Based Study
Bojing Liu, Fang Fang, Weimin Ye, Karin Wirdefeldt · 2020 · Frontiers in Neurology
The Two Faces of Exosomes in Parkinson’s Disease: From Pathology to Therapy
María Izco, Estefanía Carlos, Lydia Alvarez‐Erviti · 2021 · The Neuroscientist
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
Rubén Pavia-Collado, Valentín Cóppola-Segovia, Lluís Miquel-Rio, Diana Alarcón-Arís, Raquel Rodríguez-Aller, María Torres‐López, Verónica Paz, Esther Ruiz‐Bronchal, Leticia Campa, Francesc Artigas et al. · 2021 · International Journal of Molecular Sciences
Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
Jiayi Li, Wen Li · 2021 · Frontiers in Cell and Developmental Biology
Current Approaches and Molecular Mechanisms for Directly Reprogramming Fibroblasts Into Neurons and Dopamine Neurons
Fabin Han, Yanming Liu, Jin Huang, Xiaoping Zhang, Chuanfei Wei · 2021 · Frontiers in Aging Neuroscience
Significance and limitation of the pathological classification of TDP ‐43 proteinopathy
Tetsuaki Arai · 2014 · Neuropathology
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
Sebastian Heinzel, Maike Gold, Christian Deuschle, Felix P. Bernhard, Walter Maetzler, Daniela Berg, Richard C. Dodel · 2014 · PLoS ONE
Propagation of host disease to grafted neurons: Accumulating evidence
Jeffrey H. Kordower, Patrik Brundin · 2009 · Experimental Neurology
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
Natalia Fernández‐Borges, Hasier Eraña, Saioa R. Elezgarai, Chafik Harrathi, Mayela Gayosso, Joaquı́n Castilla · 2013 · International Journal of Cell Biology
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
Helena Borland Madsen, Frederik Vilhardt · 2017 · International Journal of Molecular Sciences
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology
Lei Mou, Wei Ding, Pedro Fernández-Fúnez · 2019 · Journal of Medical Genetics
Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species
Anna Rosa Carta, Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Ezio Carboni, Alfonso De Simone · 2020 · Journal of Neuroscience Methods
Intercellular transmission of alpha-synuclein
Shenjie Wu, Randy W. Schekman · 2024 · Frontiers in Molecular Neuroscience
Modulating SQSTM1/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate α-synuclein aggregates and boost therapy of Parkinson’s disease
Hanghang Liu, Qing Yin Zheng, Jiaxin Yuan, Yifan Gao, Tingting Wang, Hao Zhang, Zhen Li · 2023 · Nano Today
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
Matthias Schmitz, Niccolò Candelise, Sezgi Canaslan, Hermann C. Altmeppen, Jakob Matschke, Markus Glatzel, Neelam Younas, Saima Zafar, Péter Hermann, Inga Zerr · 2023 · Translational Neurodegeneration
Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease.
Tae Beom Ahn, J. William Langston, Venkat Raghav Aachi, Dennis W. Dickson · 2012 · Europe PMC (PubMed Central)
Disease-modifying therapeutic directions for Lewy-Body dementias
Qiang Zhang, Young-Cho Kim, Nandakumar S. Narayanan · 2015 · Frontiers in Neuroscience
The pallidopyramidal syndromes
Eleanna Kara, John Hardy, Henry Houlden · 2013 · Current Opinion in Neurology
Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?
Vincenzo Silani, Cinzia Calzarossa, Lidia Cova, Nicola Ticozzi · 2010 · CNS & Neurological Disorders - Drug Targets
Neuron-to-Neuron Transmission of Neurodegenerative Pathology
Martin Hallbeck, Sangeeta Nath, Jan O. Marcusson · 2013 · The Neuroscientist
LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson’s Disease
Cheol Hwan Hyun, Chae Young Yoon, He-Jin Lee, Seung‐Jae Lee · 2013 · Experimental Neurobiology
Terapia gênica: o que é, o que não é e o que será
Rafael Linden · 2010 · Estudos Avançados
Alpha-synuclein in salivary gland as biomarker for Parkinson’s disease
Flaminia Campo, Raffaella Carletti, Massimo Fusconi, Clelia Pellicano, Francesco Ernesto Pontieri, Cira Rosaria Tiziana Di Gioia, Marco DE VINCENTIIS · 2018 · Reviews in the Neurosciences
Extracellular α‐synuclein enters dopaminergic cells by modulating flotillin‐1–assisted dopamine transporter endocytosis
Junpei Kobayashi, Takafumi Hasegawa, Naoto Sugeno, Shun Yoshida, Tetsuya Akiyama, Koki Fujimori, Hiroyasu Hatakeyama, Yasuo Miki, Arata Tomiyama, Yasushi Kawata et al. · 2019 · The FASEB Journal
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson’s Disease
Biancamaria Longoni, Irene Fasciani, Shivakumar Kolachalam, Ilaria Pietrantoni, Francesco Marampon, Francesco Petragnano, Gabriella Aloisi, Maria Francesca Coppolino, Mario Rossi, Marco Scarselli et al. · 2019 · Current Pharmaceutical Design
The dual role of c‐src in cell‐to‐cell transmission of α‐synuclein
Yu Ree Choi, Jae‐Bong Kim, Seo‐Jun Kang, Hye Rin Noh, Ilo Jou, Eun-hye Joe, Sang Myun Park · 2020 · EMBO Reports
Parkinson’s Disease: A Prionopathy?
Sarah Vascellari, Aldo Manzin · 2021 · International Journal of Molecular Sciences
Etiology and Pathogenesis of Parkinson’s Disease
Taku Hatano, Nobutaka Hattori · 2011 · InTech eBooks
Invited review: Utilizing peripheral nerve regenerative elements to repair damage in the CNS
Nader El Seblani, Andrew S. Welleford, Jorge E. Quintero, Craig G. van Horne, Greg A. Gerhardt · 2020 · Journal of Neuroscience Methods
Considerations Regarding the Etiology and Future Treatment of Autosomal Recessive Versus Idiopathic Parkinson Disease
Tohru Kitada, Julianna J. Tomlinson, Hei Sio Ao, David A. Grimes, Michael G. Schlossmacher · 2012 · Current Treatment Options in Neurology
Neurodegenerative lesions: Seeding and spreading
Charles J. Duyckaerts · 2013 · Revue Neurologique
Vertebrate food products as a potential source of prion-like α-synuclein
Bryan A. Killinger, Viviane Labrie · 2017 · npj Parkinson s Disease
Dementia associated with disorders of the basal ganglia
Karina S. Vitanova, Katie M. Stringer, Diana P. Benítez, Jonathan Brenton, Damian M. Cummings · 2019 · Journal of Neuroscience Research
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects
F. González-Lizárraga, D. Ploper, C. Ávila, S. B. Socias, Maurício dos-Santos-Pereira, Belén Machin, E. Del-Bel, P. Michel, L. Pietrasanta, R. Raisman-Vozari et al. · 2020 · Scientific Reports
Passive Immunization in Alpha-Synuclein Preclinical Animal Models
Jonas Folke, Nelson Ferreira, Tomasz Brudek, Per Borghammer, Nathalie Van Den Berge · 2022 · Biomolecules
Porphyromonas gingivalis: A key role in Parkinson's disease with cognitive impairment?
Dongcheng Li, Tengzhu Ren, Hao Li, Geng Liao, Xiong Zhang · 2022 · Frontiers in Neurology
Dopamine cell transplantation in Parkinson's disease: challenge and perspective
Yilong Ma, Shichun Peng, VIJAY M. DHAWAN, David Eidelberg · 2011 · British Medical Bulletin
Cognitive Deficits after Cerebral Ischemia and Underlying Dysfunctional Plasticity: Potential Targets for Recovery of Cognition
Holly M Stradecki, Charles H. Cohan, Ami P. Raval, Kunjan R. Dave, Diego Reginensi, Rolando A. Gittens, Mehdi Youbi, Miguel A. Pérez‐Pinzón · 2017 · Journal of Alzheimer s Disease
Bottoms up: the role of gut microbiota in brain health
Nina Radisavljevic, Mihai S. Cirstea, B. Brett Finlay · 2018 · Environmental Microbiology
Alpha-synuclein: prion or prion-like?
Rehana K. Leak, Matthew P. Frosch, Thomas G. Beach, Glenda Margaret Halliday · 2019 · Acta Neuropathologica
LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models
Dylan J. Dues, Darren J. Moore · 2020 · Frontiers in Neuroscience
Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model
Tae‐Gyun Woo, Min-Ho Yoon, So‐mi Kang, So‐Young Park, Jung-Hyun Cho, Young Jun Hwang, Jinsook Ahn, Hyewon Jang, Yun-Jeong Shin, Eui‐Man Jung et al. · 2021 · Communications Biology
Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease
Sang Myun Park, Kwang Soo Kim · 2013 · Prion
α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization
Benjamin Feller, Aurélie Fallon, Wen Luo, Phuong Trang Nguyen, Irina Shlaifer, Alfred Kihoon Lee, Nicolas Chofflet, Nayoung Yi, Husam Khaled, Samer Karkout et al. · 2023 · Cells
New opportunities for antioxidants in amelioration of neurodegenerative diseases
Uttam Raj Bhandari, Syed Mohammad Danish, Shadaan Ahmad, Mohammad Ikram, Arif Nadaf, Nazeer Hasan, Prashant Kesharwani, Farhan J. Ahmad · 2024 · Mechanisms of Ageing and Development
The history and status of dopamine cell therapies for Parkinson's disease
Roger A. Barker, Anders Björklund, Malin Parmar · 2024 · BioEssays
Focusing Brain Therapeutic Interventions in Space and Time for Parkinson’s Disease
Simon J Little, Peter Brown · 2014 · Current Biology
Sensing α‐Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration
Inês Caldeira Brás, Luísa Vaqueiro Lopes, Tiago F. Outeiro · 2018 · Movement Disorders
Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment
Devina Chetty, Shameemah Abrahams, Riaan van Coller, Jonathan Ambrose Carr, Colin P. Kenyon, Soraya Bardien · 2021 · European Journal of Neuroscience
Prion protein and prion disease at a glance
Caihong Zhu, Adriano Aguzzi · 2021 · Journal of Cell Science
Predicting longitudinal brain atrophy in Parkinson’s disease using a Susceptible-Infected-Removed agent-based model
Alaa Abdelgawad, Shady Rahayel, Ying‐Qiu Zheng, Christina Tremblay, Andrew Vo, Bratislav Mišić, Alain Dagher · 2022 · Network Neuroscience
Neural tissue transplantation, repair, and rehabilitation
Stephen B. Dunnett · 2013 · Handbook of clinical neurology
Comparison of Fetal Mesencephalic Grafts, AAV-delivered GDNF, and Both Combined in an MPTP-induced Nonhuman Primate Parkinson’s Model
Donald Eugene Redmond, Caleb R.S. McEntire, Joseph P Kingsbery, Csaba Léránth, John D. Elsworth, Kimberly B. Bjugstad, Robert Howard Roth, Richard Jude Samulski, John R. Sladek · 2013 · Molecular Therapy
Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells
Jiali Pu, Houbo Jiang, Baorong Zhang, Jian Feng · 2012 · Current Neurology and Neuroscience Reports
Secrets of the shaking palsy
Jim Schnabel · 2010 · Nature
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Milica Marković, Pravin Yeapuri, Krista L. Namminga, Yaman Lu, Maamoon Saleh, Katherine E. Olson, Howard Eliot Gendelman, Rodney Lee Mosley · 2022 · NeuroImmune Pharmacology and Therapeutics
Transgenic Mouse Models for the Study of Neurodegenerative Diseases
Alba Marín‐Moreno, Sara Canoyra, Natalia Fernández‐Borges, Juan Carlos Espinosa, Juan María Torres · 2023 · Frontiers in Bioscience-Landmark
Sex and Age Differences in a Progressive Synucleinopathy Mouse Model
Jérôme Lamontagne‐Proulx, Katherine Coulombe, Marc Morissette, Marie Rieux, Frédéric Calon, Thérèse Di Paolo, Denis Soulet · 2023 · Biomolecules
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Virginie Licker, Pierre R. Burkhard · 2014 · Translational Proteomics
Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases
Eva Tomaskovic‐Crook, Jeremy Micah Crook · 2011 · CNS & Neurological Disorders - Drug Targets
Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation
Laura Torres-Garcia, Joana M. P. Domingues, Edoardo Brandi, Caroline Haikal, Janitha M. Mudannayake, Inês Caldeira Brás, Ellen Gerhardt, Wen Li, Alexander Svanbergsson, Tiago F. Outeiro et al. · 2022 · Scientific Reports
Perivascular Mesenchymal Stem Cells From the Adult Human Brain Harbor No Instrinsic Neuroectodermal but High Mesodermal Differentiation Potential
Xenia Lojewski, Sumitra Srimasorn, Juliane Rauh, Silvan Francke, Manja Wobus, Verdon Taylor, Marcos Jesus Araúzo-Bravo, Susanne Hallmeyer‐Elgner, Matthias Kirsch, Sigrid C. Schwarz et al. · 2015 · Stem Cells Translational Medicine
A Systematic Review of Extracellular Matrix-Related Alterations in Parkinson’s Disease
Mary Ann Chapman, Barbara A. Sorg · 2024 · Brain Sciences
Motor cortical neuronal hyperexcitability associated with α-synuclein aggregation
Liqiang Chen, Hiba Douja Chehade, Hong‐Yuan Chu · 2025 · npj Parkinson s Disease